Phathom Pharmaceuticals Inc. (PHAT)
Market Closed
10 Sep, 20:00
NASDAQ (NGS) NASDAQ (NGS) Primary $
8. 37
-0.3
-3.4602%
Pre Market
$
+0.2 +2.3895% 8. 57
762.9M Market Cap
- P/E Ratio
- Div Yield
1.09M Volume
-4.59 Eps
$ 8.67
Previous Close 
Want to track PHAT and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Phathom Pharmaceuticals Inc. (PHAT) Statistics
Valuation metrics
Market Cap 762.9M
Enterprise value 753.19M
Trailing P/E (ttm) -7.42
Forward P/E -
PEG ratio -0.05
Price/Sales (ttm) 3.21
Price/Book (mrq) -2.31
Enterprise Value/Revenue 3.14
Enterprise Value/EBITDA -21.44
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 1.08M
Average volume (90 days) 1.57M
Price summary
52-Week low 8.21
52-Week high 18.31
Beta -
50-Day moving average 10.43
200-Day moving average 11.38
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -0.41%
Operating margin -0.17%
Operational effectiveness
Return on assets -0.3%
Return on equity 0.26%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 2.86
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -1.18
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 2.18
Total debt (mrq) -
Total Debt/Equity (mrq) -0.49
Current ratio (mrq) 1.92%
Book value per share (mrq) -4.11
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
